A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody".

J Dermatol

Published: January 2023

Download full-text PDF	Source
http://dx.doi.org/10.1111/1346-8138.16587	DOI Listing

Publication Analysis

dermatomyositis anti-transcription

anti-transcription intermediary

intermediary factor

case juvenile

juvenile amyopathic

amyopathic dermatomyositis

factor 1-α

1-α antibody

antibody showing

showing negative

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!